Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015

1/11/2023, 1:31 PM

Congressional Summary of HR 2570

Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act of 2015

(Sec. 2) This bill amends title XVIII (Medicare) of the Social Security Act (SSAct) with respect to criteria for qualifying as a meaningful user of electronic health records (meaningful EHR user). For any payment year after 2015 any patient encounter of an eligible professional occurring at an eligible ambulatory surgical center shall not be treated as one in determining whether an eligible professional qualifies as a meaningful EHR user.

(Sec. 3) HHS shall establish a three-year demonstration program to test the use of value-based insurance design methodologies under the eligible Medicare Advantage (MA) plans offered by MA organizations under Medicare part C.

"Value-based insurance design methodology" is one for identifying specific prescription medications, and clinical services payable under Medicare, for which copayments, coinsurance, or both would improve the management of specific chronic clinical conditions because of the high value and effectiveness of such medications and services for such specific chronic clinical conditions, as approved by HHS.

HHS may expand the duration and scope of the demonstration program to an appropriate extent if specified requirements are met.

(Sec. 4) Payment amounts are prescribed for infusion drugs and biologicals furnished through durable medical equipment (DME) on or after January 1, 2017.

(Sec. 5) It is the sense of Congress that HHS:

  • has incorrectly interpreted the determination of blended benchmark amounts as prohibiting the provision of any Medicare quality incentive payments with respect to MA plans that exceed the payment benchmark cap for the area served by those plans; and
  • should immediately apply quality incentive payments with respect to such MA plans without regard to limits.

(Sec. 6) $220 million shall be available to the Medicare Improvement Fund during and after FY2020.

(Sec. 7) DME competitive acquisition programs shall not cover infusion drugs and biologicals.

Current Status of Bill HR 2570

Bill HR 2570 is currently in the status of Bill Introduced since May 22, 2015. Bill HR 2570 was introduced during Congress 114 and was introduced to the House on May 22, 2015.  Bill HR 2570's most recent activity was Received in the Senate and Read twice and referred to the Committee on Finance. as of June 18, 2015

Bipartisan Support of Bill HR 2570

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
3
Democrat Cosponsors
2
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2570

Primary Policy Focus

Health

Potential Impact Areas

Health care costs and insuranceHealth care qualityHealth information and medical recordsHealth technology, devices, suppliesHome and outpatient careMedicarePrescription drugsSurgery and anesthesia

Alternate Title(s) of Bill HR 2570

Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015To establish a demonstration program requiring the utilization of Value-Based Insurance Design to demonstrate that reducing the copayments or coinsurance charged to Medicare beneficiaries for selected high-value prescription medications and clinical services can increase their utilization and ultimately improve clinical outcomes and lower health care expenditures.Value Based Insurance Design for Better Care Act of 2015VBID for Better Care Act of 2015Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015To amend title XVIII of the Social Security Act with respect to the treatment of patient encounters in ambulatory surgical centers in determining meaningful EHR use, establish a demonstration program requiring the utilization of Value-Based Insurance Design to demonstrate that reducing the copayments or coinsurance charged to Medicare beneficiaries for selected high-value prescription medications and clinical services can increase their utilization and ultimately improve clinical outcomes and lower health care expenditures, and for other purposes.
Start holding our government accountable!

Comments

Latest Bills

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Waste Emissions Charge for Petroleum and Natural Gas Systems: Procedures for Facilitating Compliance, Including Netting and Exemptions".
Bill HJRES 35March 29, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of Energy Efficiency and Renewable Energy, Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Commercial Refrigerators, Freezers, and Refrigerator-Freezers".
Bill HJRES 75March 29, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Walk-In Coolers and Walk-In Freezers".
Bill HJRES 24March 29, 2025
No 340B Savings for Transgender Care Act
Bill HR 2197March 29, 2025
Major Richard Star Act
Bill HR 2102March 29, 2025
Ending China’s Unfair Advantage Act of 2025
Bill HR 2115March 29, 2025
IMPACT Act 2.0
Bill HR 2122March 29, 2025
Protecting Individuals with Down Syndrome Act
Bill HR 2251March 29, 2025
To amend title 14, United States Code, to require the retention of certain enlisted members of the Coast Guard who have completed 18 or more, but less than 20, years of service, and for other purposes.
Bill HR 2200March 29, 2025
Feed Hungry Veterans Act of 2025
Bill HR 2195March 29, 2025
Value-Based Insurance Design Seniors Copayment Reduction Act of 2015
Bill S 1396January 11, 2023
Preservation of Access for Seniors in Medicare Advantage Act of 2015
Bill HR 2581January 11, 2023